Funder
Alzheimer's Disease Neuroimaging Initiative
DOD ADNI
National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Cogstate
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
Canadian Institutes of Health Research
Brain Imaging, APOE and the Preclinical Course of Alzheimer's Disease
Alzheimer's Disease Core Center
Alzheimer's Prevention Initiative
Alzheimer's Prevention Initiative APOE4 Trial
ADNI
State of Arizona
Subject
Cognitive Neuroscience,Clinical Neurology,Neurology,Radiology Nuclear Medicine and imaging